Jobs / United States / Beam Therapeutics INC
Senior Director, CMC Operations
Beam Therapeutics INC · 🇺🇸 Cambridge, MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 7 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Beam Therapeutics INC paid sponsored hires in similar roles2 certified filings for “Senior Director, Regulatory Affairs” (Regulatory Affairs Managers) in MA: $223k–$223k, median $223k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Beam Therapeutics INC
The US Department of Labor certified 7 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Beam Therapeutics INC →
About the role
Company Overview: Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. Position Overview: Beam is seeking a highly talented and motivated Sr. Director / Director of CMC, to lead our advancing portfolio of in-vivo and ex-vivo programs. Serving as a subject matter expert, this leader will be accountable for all CMC deliverables spanning the lifecycle of the product from IND submission through BLA approval. The candidate will define the strategic direction for both manufacturing processes and analytical methods, partnering closely with key stakeholders across the business. This is a high-impact leadership role requiring a data-driven, collaborative, results-oriented professional to ensure the integrated control strategy is appropriate for the product as the program moves through clinical development into commercial. This person will be responsible for comprehensive communication across all levels of the business, status reporting, risk management, escalation and resolution of issues. Primary Responsibilities: • Provides strategic, technical, and tactical leadership for a portfolio of in-vivo CMC programs. • Accountable for all CMC program deliverables to enable an IND through a BLA. • Develop and implement strategic direction for analytical methods partnering with Analytical Development and Quality Control. • Develop and implement strategic directions for manufacturing processes partnering with process development, MS&T, and manufacturing. • Lead the CMC sub-team(s) and cross-functional sub teams under the direction of the Program team(s). • Develop and implement comprehensive product lifecycle strategies around process / analytical development, manufacturing, and quality control in conjunction with Quality Assurance, Quality Control, Manufacturing, Process, and Analytical Development. • Develop comparability strategies and author protocols to support product lifecycle changes for process changes, analytical changes, and secondary suppliers. • Work directly with regulatory and key stakeholders on the development and implementation of platform processes and analytics across the CMC product lifecycle for in-vivo programs. • Lead the preparation of source documentation and technical review of CMC sections for global regulatory submissions specifically focusing on Module 3. • Act as the CMC subject matter expert during regulatory meetings and support information requests from regulatory agencies. • Serve as a subject matter expert for process and analytical challenges while being accountable for driving to a resolution. • Drive accountability for cross functional partners to meet CMC program timelines and deliverables such as drug supply planning to meet clinical and commercial needs. • Actively identify risks across all CMC areas during the product lifecycle. Oversee data-driven risk assessments and drive implementation of risk mitigations. • Actively participate in the strategic design and execution of Extractables and